Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury

American Journal of Physiology - Renal Physiology

Volumn 287, Issue 4 56-4, 2004, Pages

  Kelly, K J ^a   Sutton, T A ^a   Weathered, N ^a   Ray, N ^a   Caldwell, E J ^a   Plotkin, Z ^a   Dagher, P C ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b Nephrology Division   (United States)

Author keywords

Acute renal failure; Cytochrome c; P53; Tetracyclines

Indexed keywords

CREATININE; CYTOCHROME C; INTERCELLULAR ADHESION MOLECULE 1; MINOCYCLINE; PROTEIN BAX; PROTEIN P53; TETRACYCLINE DERIVATIVE;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTERY CLAMP; ARTICLE; CELL INFILTRATION; CELL NUCLEUS; CELL STRUCTURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG POTENCY; ENZYME RELEASE; INFLAMMATION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; LEUKOCYTE; MALE; NEUTROPHIL CHEMOTAXIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

EID: 4644308652     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00050.2004     Document Type: Article

References (34)

1. Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, and Holtzman DM. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 52: 54-61, 2002.
2. Bonegio R and Lieberthal W. Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11: 301-308, 2002.
3. Bonventre JV and Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199-2210, 2003.
4. Burne-Taney MJ and Rabb H. The role of adhesion molecules and T cells in ischemic renal injury. Curr Opin Nephrol Hypertens 12: 85-90, 2003.
5. Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, and Friedlander RM. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6: 797-801, 2000.
6. Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, and Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101: 1833-1839, 2000.
7. Daemen MA, van't Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clause M, Vandenabeele P, and Buurman WA. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104: 541-549, 1999.
8. Dagher PC, Herget-Rosenthal S, Ruehm SG, Jo SK, Star RA, Agarwal R, and Molitoris BA. Newly developed techniques to study and diagnose acute renal failure. J Am Soc Nephrol 14: 2188-2198, 2003.
9. Duckett CS, Li F, Wang Y, Tomaselli KJ, Thompson CB, and Armstrong RC. Human IAP-like protein regulates programmed cell death downstream of Bcl-xL and cytochrome c. Mol Cell Biol 18: 608-615, 1998.
10. Dunn KW, Sandoval RM, Kelly KJ, Dagher PC, Tanner GA, Atkinson SJ, Bacallao RL, and Molitoris BA. Functional studies of the kidney of living animals using multicolor two-photon microscopy. Am J Physiol Cell Physiol 283: C905-C916, 2002.
11. Gelber RH, Siu P, Tsang M, Alley P, and Murray LP. Effect of low-level and intermittent minocycline therapy on the growth of Mycobacterium leprae in mice. Antimicrob Agents Chemother 35: 992-994, 1991.
12. Kelly KJ, Plotkin Z, and Dagher PC. Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. J Clin Invest 108: 1291-1298, 2001.
13. Kelly KJ, Plotkin Z, Vulgamott SL, and Dagher PC. p53 Mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. J Am Soc Nephrol 14: 128-138, 2003.
14. Kelly KJ, Sandoval RM, Dunn KW, Molitoris BA, and Dagher PC. A novel method to determine specificity and sensitivity of the TUNEL reaction in the quantitation of apoptosis. Am J Physiol Cell Physiol 284: C1309-C1318, 2003.
15. Kelly KJ, Williams WW Jr, Colvin RB, and Bonventre JV. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 91: 812-816, 1994.
16. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, and Bonventre JV. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97: 1056-1063, 1996.
17. Naline E, Sanceaume M, Toty L, Bakdach H, Pays M, and Advenier C. Penetration of minocycline into lung tissues. Br J Clin Pharmacol 32: 402-404, 1991.
18. Nieman GF and Zerler BR. A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury. Curr Med Chem 8: 317-325, 2001.
19. Padanilam BJ. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 284: F608-F627, 2003.
20. Park MS, De Leon M, and Devarajan P. Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 13: 858-865, 2002.
21. Pijpers A, Schoevers EJ, Haagsma N, and Verheijden JH. Plasma levels of oxytetracycline, doxycycline, and minocycline in pigs after oral administration in feed. J Anim Sci 69: 4512-4522, 1991.
22. Power C, Henry S, Del Bigio MR, Larsen PH, Corbett D, Imai Y, Yong VW, and Peeling J. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol 53: 731-742, 2003.
23. Rabb H, O'Meara YM, Maderna P, Coleman P, and Brady HR. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 51: 1463-1468, 1997.
24. Siegel NJ and Shah SV. Acute renal failure: directions for the next decade. J Am Soc Nephrol 14: 2176-2177, 2003.
25. Simon C, Malerczyk V, Engelke H, Preuss I, Grahmann H, and Schmidt K. The pharmacokinetics of doxycycline in kidney insufficiency in geriatric patients compared with younger adults. Schweiz Med Wochenschr 105: 1615-1620, 1975.
26. Simon C, Malerczyk V, Preuss I, Schmidt K, and Grahmann H. Activity in vitro and pharmacokinetics of minocycline. Arzneimittelforschung 26: 556-560, 1976.
27. Tamatani T and Miyasaka M. Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting vs. activated lymphocytes to high endothelial cells. Int Immunol 2: 165-171, 1990.
28. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, and Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21: 2580-2588, 2001.
29. Tikka T, Usenius T, Tenhunen M, Keinanen R, and Koistinaho J. Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation. J Neurochem 78: 1409-1414, 2001.
30. Tikka TM, Vartiainen NE, Goldsteins G, Oja SS, Andersen PM, Marklund SL, and Koistinaho J. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neuron disease. Brain 125: 722-731, 2002.
31. Villarreal FJ, Griffin M, Omens J, Dillmann W, Nguyen J, and Covell J. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling. Circulation 108: 1487-1492, 2003.
32. Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, and Friedlander RM. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci USA 100: 10483-10487, 2003.
33. Watanabe A, Anzai Y, Niitsuma K, Saito M, Yanase K, and Nakamura M. Penetration of minocycline hydrochloride into lung tissue and sputum. Chemotherapy 47: 1-9, 2001.
34. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu du C, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, and Friedlander RM. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417: 74-78, 2002.